MX2016008418A - Metodos y reactivos para el radiomarcaje. - Google Patents
Metodos y reactivos para el radiomarcaje.Info
- Publication number
- MX2016008418A MX2016008418A MX2016008418A MX2016008418A MX2016008418A MX 2016008418 A MX2016008418 A MX 2016008418A MX 2016008418 A MX2016008418 A MX 2016008418A MX 2016008418 A MX2016008418 A MX 2016008418A MX 2016008418 A MX2016008418 A MX 2016008418A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- present
- provides
- radiolabeling
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000000163 radioactive labelling Methods 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003481 heat shock protein 90 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919901P | 2013-12-23 | 2013-12-23 | |
| PCT/US2014/072090 WO2015138039A1 (en) | 2013-12-23 | 2014-12-23 | Methods and reagents for radiolabeling |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016008418A true MX2016008418A (es) | 2017-01-11 |
Family
ID=54072256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016008418A MX2016008418A (es) | 2013-12-23 | 2014-12-23 | Metodos y reactivos para el radiomarcaje. |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9994573B2 (enExample) |
| EP (1) | EP3086792B1 (enExample) |
| JP (1) | JP6491214B2 (enExample) |
| KR (1) | KR102325454B1 (enExample) |
| CN (1) | CN106456645B (enExample) |
| AU (1) | AU2014386214B2 (enExample) |
| BR (1) | BR112016014758A8 (enExample) |
| CA (1) | CA2934850C (enExample) |
| IL (1) | IL246403B (enExample) |
| MX (1) | MX2016008418A (enExample) |
| RU (1) | RU2016128528A (enExample) |
| TW (1) | TWI673279B (enExample) |
| WO (1) | WO2015138039A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015138039A1 (en) | 2013-12-23 | 2015-09-17 | Memorial Sloan-Kettering Cancer Center | Methods and reagents for radiolabeling |
| MX387627B (es) * | 2014-09-17 | 2025-03-18 | Memorial Sloan Kettering Cancer Center | Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia |
| WO2017002196A1 (ja) * | 2015-06-30 | 2017-01-05 | 株式会社日立国際電気 | 整合器及び整合方法 |
| KR102175125B1 (ko) * | 2018-12-28 | 2020-11-05 | 울산과학기술원 | 미토콘드리아 표적 Hsp90 억제제 기반 화합물 및 이를 포함하는 광역학 치료를 위한 약학적 조성물 |
| WO2022182731A1 (en) * | 2021-02-24 | 2022-09-01 | Samus Therapeutics, Inc. | Sn-labeling and radiolabeling of epichaperome inhibitors |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US20070178537A1 (en) * | 2003-06-30 | 2007-08-02 | Sloan-Kettering Institute For Cancer Research | Assays for detection of bioactive compounds that interact with heat shock protein 90 |
| US7834181B2 (en) | 2005-02-01 | 2010-11-16 | Slaon-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| US9403828B2 (en) | 2005-02-01 | 2016-08-02 | Sloan-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| WO2007134298A2 (en) | 2006-05-12 | 2007-11-22 | Myriad Genetics, Inc. | Therapeutic compounds and their use in cancer |
| WO2008005937A2 (en) | 2006-06-30 | 2008-01-10 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases through inhibiton of hsp90 |
| KR101313804B1 (ko) | 2007-03-20 | 2013-10-01 | 쿠리스 인코퍼레이션 | Ｈｓｐ９０ 억제제로서의 융합된 아미노 피리딘 |
| NZ586129A (en) | 2007-11-14 | 2012-06-29 | Myrexis Inc | Therapeutic compounds and their use in treating diseases and disorders |
| JP5941407B2 (ja) | 2009-10-07 | 2016-06-29 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Ｈｓｐ９０阻害剤 |
| CN103596955B (zh) | 2011-04-05 | 2016-11-16 | 索隆-基特林癌症研究协会 | Hsp90抑制剂 |
| JP6266506B2 (ja) | 2011-04-05 | 2018-01-24 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Ｈｓｐ９０阻害物質 |
| BR112013027448A2 (pt) | 2011-04-28 | 2020-09-01 | Sloan-Kettering Institute For Cancer Research | terapia de combinação com hsp90 |
| EA201490230A1 (ru) | 2011-07-08 | 2014-06-30 | Слоан-Кеттеринг Инститьют Фор Кэнсер Рисерч | Применение меченых ингибиторов hsp90 |
| EP2972394A4 (en) * | 2013-03-15 | 2016-11-02 | Sloan Kettering Inst Cancer | HSP90-DESIGNING AND THERAPY |
| SG11201601542SA (en) | 2013-08-16 | 2016-04-28 | Sloan Kettering Inst Cancer | Selective grp94 inhibitors and uses thereof |
| WO2015138039A1 (en) | 2013-12-23 | 2015-09-17 | Memorial Sloan-Kettering Cancer Center | Methods and reagents for radiolabeling |
| MX387627B (es) | 2014-09-17 | 2025-03-18 | Memorial Sloan Kettering Cancer Center | Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia |
| US20180280397A1 (en) | 2015-10-05 | 2018-10-04 | Memorial Sloan Kettering Cancer Center | Rational combination therapy for the treatment of cancer |
-
2014
- 2014-12-23 WO PCT/US2014/072090 patent/WO2015138039A1/en not_active Ceased
- 2014-12-23 TW TW103145077A patent/TWI673279B/zh not_active IP Right Cessation
- 2014-12-23 RU RU2016128528A patent/RU2016128528A/ru unknown
- 2014-12-23 CA CA2934850A patent/CA2934850C/en active Active
- 2014-12-23 MX MX2016008418A patent/MX2016008418A/es unknown
- 2014-12-23 CN CN201480076193.7A patent/CN106456645B/zh not_active Expired - Fee Related
- 2014-12-23 KR KR1020167019985A patent/KR102325454B1/ko not_active Expired - Fee Related
- 2014-12-23 JP JP2016542216A patent/JP6491214B2/ja not_active Expired - Fee Related
- 2014-12-23 AU AU2014386214A patent/AU2014386214B2/en not_active Ceased
- 2014-12-23 EP EP14885717.0A patent/EP3086792B1/en not_active Not-in-force
- 2014-12-23 US US15/107,229 patent/US9994573B2/en active Active
- 2014-12-23 BR BR112016014758A patent/BR112016014758A8/pt not_active Application Discontinuation
-
2016
- 2016-06-22 IL IL246403A patent/IL246403B/en active IP Right Grant
-
2018
- 2018-05-04 US US15/971,908 patent/US10329293B2/en active Active
-
2019
- 2019-04-26 US US16/396,496 patent/US10793570B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP3086792B1 (en) | 2022-10-12 |
| CA2934850C (en) | 2022-12-06 |
| BR112016014758A8 (pt) | 2020-06-02 |
| US20200017502A1 (en) | 2020-01-16 |
| IL246403B (en) | 2020-08-31 |
| US20170029426A1 (en) | 2017-02-02 |
| TWI673279B (zh) | 2019-10-01 |
| RU2016128528A (ru) | 2018-01-30 |
| BR112016014758A2 (enExample) | 2017-08-08 |
| AU2014386214B2 (en) | 2020-05-21 |
| JP6491214B2 (ja) | 2019-03-27 |
| EP3086792A4 (en) | 2017-05-24 |
| US20180251461A1 (en) | 2018-09-06 |
| CN106456645A (zh) | 2017-02-22 |
| AU2014386214A1 (en) | 2016-07-14 |
| WO2015138039A1 (en) | 2015-09-17 |
| EP3086792A1 (en) | 2016-11-02 |
| CN106456645B (zh) | 2021-03-23 |
| KR102325454B1 (ko) | 2021-11-16 |
| US9994573B2 (en) | 2018-06-12 |
| CA2934850A1 (en) | 2015-09-17 |
| US10329293B2 (en) | 2019-06-25 |
| KR20160101186A (ko) | 2016-08-24 |
| US10793570B2 (en) | 2020-10-06 |
| IL246403A0 (en) | 2016-08-31 |
| TW201609773A (zh) | 2016-03-16 |
| JP2017502039A (ja) | 2017-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014502697A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| MX2015015421A (es) | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. | |
| MX2015015417A (es) | Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos. | |
| NZ726859A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| PH12018500408A1 (en) | Bicyclic compounds as atx inhibitors | |
| TN2015000420A1 (en) | Novel compounds and compositions for inhibition of fasn | |
| PH12015500263A1 (en) | New bicyclic derivatives | |
| MX381456B (es) | Regulador de ph de transduccion. | |
| PH12018500409A1 (en) | New bicyclic compounds as dual atx/ca inhibitors | |
| MX358376B (es) | Nuevos derivados dihidroquinolina-2-ona. | |
| EA201590887A1 (ru) | Композиция | |
| PH12014500814A1 (en) | New aryl-quinoline derivatives | |
| MY176465A (en) | Synthetic route to 2?-deoxy-2?,2?-difluorotetrahydrouridines | |
| MX2016008418A (es) | Metodos y reactivos para el radiomarcaje. | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
| PH12014501781A1 (en) | Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith | |
| CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
| EA201590729A1 (ru) | Производные 3,4-дизамещенного оксазолидинона и их применение в качестве ингибиторов кальцийактивируемых калиевых каналов | |
| IN2014DN10135A (enExample) | ||
| MX2015009377A (es) | Compuestos radiomarcados. | |
| MX391523B (es) | Intermediarios y metodos para sintetizar derivados de calicheamicina | |
| MX2014008856A (es) | Derivados de imidazolilcetona como inhibidores de aldosterona sintasa. | |
| MX344429B (es) | Nuevos compuestos de hexahidropirroloimidazolona. | |
| IN2013CH05394A (enExample) | ||
| NZ751449A (en) | Novel compounds and compositions for inhibition of fasn |